mr JAMES GREENWOOD

Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs. H.R. 4408/S. 1906, Promising Pathway Act.

H.R. 4365/S. 2587, Department of Defense Appropriations, FY2024, support for data-driven products and services. Government contracting issues. H.R. 5894/S. 2624, Labor/HHS/Education Appropriations, FY2024, support for data-driven products and services. Reauthorization of the Pandemic and All Hazards Preparedness Act.

Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.

Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs.

Implementation of the Infrastructure Investment and Jobs Act, Pub. L. No. 117-58, provisions related to biologic wastage rebates.

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.

H.R. 4365, Department of Defense Appropriations, FY2024, support for data-driven products and services. Government contracting issues. H.R. 5894, Labor/HHS/Education Appropriations, FY2024, support for data-driven products and services. Reauthorization of the Pandemic and All Hazards Preparedness Act.

Legislative and regulatory policies and proposals related to obesity treatment, including H.R. 4818/S. 2408, the Treat and Reduce Obesity Act of 2023.

Legislative and regulatory policies and proposals related to obesity treatment, including the Treat and Reduce Obesity Act of 2023.

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Implementation of the Infrastructure Investment and Jobs Act, Pub. L. No. 117-58, provisions related to biologic wastage rebates.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test.

H.R. 4365, Department of Defense Appropriations, FY2024, support for data-driven products and services. Government contracting issues. Labor/HHS/Education Appropriations, FY2024, support for data-driven products and services. Reauthorization of the Pandemic and All Hazards Preparedness Act.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Public Health Emergency Status. Implementation of the Inflation Reduction Act of 2022, Pub. L. No. 117-169, Medicaid provisions.

Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Public Health Emergency Status. Implementation of the Inflation Reduction Act of 2022, Pub. L. No. 117-169, Medicaid provisions.

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Implementation of the Infrastructure Investment and Jobs Act, Pub. L. No. 117-58, provisions related to biologic wastage rebates.

Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test.

Department of Defense Appropriations, FY2024, support for data-driven products and services. Government contracting issues. Labor/HHS/Education Appropriations, FY2024 support for data-driven products and services. Reauthorization of the Pandemic and All Hazards Preparedness Act.

Policies, proposals, and FDA regulation of pharmaceuticals in disease areas served by Biohaven.

Legislative and regulatory policies affecting biotechnology including: pharmaceutical development; biodefense; and diagnostics. H.R. 8295, Labor/HHS/Education Appropriations for FY2023, provisions regarding pandemic response. H.R. 5801, HELP Copays Act.

Federal contracts for biopharmaceuticals development.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test by expediting reimbursement and other regulatory processes.

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Public Health Emergency Status. Implementation of the Inflation Reduction Act of 2022, Pub. L. No. 117-169, Medicaid provisions.

Policies related to drug approval for treatment of rare diseases. Policies related to exclusivity of small molecule drugs.

Implementation of the Infrastructure Investment and Jobs Act, Pub. L. No. 117-58, provisions related to biologic wastage rebates.

H.R. 8236, Department of Defense Appropriations, FY2023, support for data-driven products and services. Government contracting issues. S. 3904, Healthcare Cybersecurity Act of 2022.

Policies, proposals, and FDA regulation of pharmaceuticals in disease areas served by Biohaven.

Issues surrounding implementation of Infrastructure Investment and Jobs Act.

Federal contracts for biopharmaceuticals development.

H.R. 8236, Department of Defense Appropriations, FY2023, support for data-driven products and services.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic. H.R. 5376, Inflation Reduction Act of 2022, Medicaid provisions.

Legislative and regulatory policies affecting biotechnology including: pharmaceutical development; biodefense; and diagnostics. H.R. 8295, Labor/HHS/Education Appropriations for FY2023, provisions regarding pandemic response. H.R. 5801, HELP Copays Act.

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test by expediting reimbursement and other regulatory processes.

Issues related to drug pricing, Medicare reimbursement, implementation of the Inflation Reduction Act, and mental health.

H.R. 8236, Department of Defense Appropriations, FY2023, support for data-driven products and services.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic.

Federal contracts for biopharmaceuticals development.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test by expediting reimbursement and other regulatory processes.

Legislative and regulatory policies affecting biotechnology including: pharmaceutical development; biodefense; and diagnostics. H.R. 8295, Labor/HHS/Education Appropriations for FY2023, provisions regarding pandemic response. H.R. 5801, HELP Copays Act.

Department of Defense Appropriations, FY2023, support for data-driven products and services. Department of Health and Human Services Appropriations, FY2023, support for data-driven products and services.

Federal contracts for biopharmaceuticals development. S. 3799, PREVENT Pandemics Act.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test by expediting reimbursement and other regulatory processes.

Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval reimbursement, and pricing; patient assistance and access programs; and benefit redesign. H.R. 5376, Build Back Better Act, drug pricing provisions. Labor/HHS/Education Appropriations for FY2023, provisions regarding pandemic response. CMS National Coverage Determination for Alzheimer's treatment. Potential pilot program combatting influenza.

Federal market support for data-driven products and services.

Federal contracts for biopharmaceuticals development.

Provisions relating to the manufacturing priorities for biopharmaceuticals.

Implementation of the American Rescue Plan Act of 2021, Pub. L. No. 117-2. H.R. 4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2022, provisions regarding higher education.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test by expediting reimbursement and other regulatory processes.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic. H.R. 2166, Ensuring Parity in MA and PACE for Audio-Only Telehealth Act. S. 1333, MOMS Act. S. Con. Res. 14, Budget Reconciliation Act, funding to close the Medicaid Coverage Gap.

Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval, reimbursement, and pricing; patient assistance and access programs; privacy; and benefit redesign. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act. H.R. 5376, Build Back Better Act, drug pricing provisions.

Provide counsel and advocacy in support of Illuminas efforts to promote competition and accelerate non-discriminatory public access to its lifesaving multi-cancer early detection test by expediting reimbursement and other regulatory processes.

Outreach to discuss the regulatory framework around indoor air quality.

Implementation of the American Rescue Plan Act of 2021, Pub. L. No. 117-2. H.R. 4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2022, provisions regarding higher education.

Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval, reimbursement, and pricing; patient assistance and access programs; privacy; and benefit redesign. H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act.

Policies related to structures for drug pricing, including legislative proposals under consideration.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic. H.R. 2166, Ensuring Parity in MA and PACE for Audio-Only Telehealth Act. S. 1333, MOMS Act. S. Con. Res. 14, Budget Reconciliation Act, funding to close the Medicaid Coverage Gap.

Legislative and regulatory policies affecting biotechnology including: pharmaceutical development, approval, reimbursement, and pricing; patient assistance and access programs; privacy; and benefit redesign.

Outreach to discuss the regulatory framework around indoor air quality.

Implementation of the American Rescue Plan Act of 2021, Pub. L. No. 117-2. H.R. 4502, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY 2022, provisions regarding higher education.

Legislative outreach regarding matters before the Federal Trade Commission.

Legislative and regulatory proposals affecting Medicaid Managed Care organizations. Medicaid extenders. Legislative proposals to respond to the coronavirus pandemic. H.R. 2166, Ensuring Parity in MA and PACE for Audio-Only Telehealth Act. S. 1333, MOMS Act.

Policies related to structures for drug pricing.

Policies related to structures for drug pricing.

Outreach to discuss the regulatory framework around indoor air quality.

Legislative outreach regarding matters before the Federal Trade Commission.

Higher education issues. H.R. 1319, the American Recovery Plan.